Telangana starts administering booster doses of Covid vaccine
Covax News Collection
-
-
Health Ministry rejects claim 'Covaxin was rushed due to political pressure'
-
Covaxin can help control virus load, reduce disease severity: Study
-
Covaxin safe for children aged 2-18 years, says Bharat Biotech
-
Covaxin booster enhances vaccine effectiveness against Delta, Omicron variants: ICMR study
-
-
Germany approves Bharat Biotech's Covaxin
-
Restricted emergency use approvals to Covishield, Covaxin not granted in haste: SC
-
Ocugen to commercialise Covaxin in Mexico
-
Bharat Biotech toes Serum line, to provide Covaxin at Rs 225; booster dose from today
-
-
Govt panel recommends Covovax inclusion in vax drive for 12 and above
-
Bharat Biotech announces slowing down of Covaxin production
-
DCGI grants regular market approval for Covishield, Covaxin with conditions
-
Covaxin booster can neutralise Omicron: Bharat Biotech
-
Covaxin booster dose trial shows 'long-term safety': Bharat Biotech
-
Paracetamol not recommended after getting Covaxin jab: Bharat Biotech
-
Covaxin for children proven to be safe in paediatric subjects in study: Bharat Biotech
-
Covaxin gets DCGI nod for emergency use for children aged 12-18
-
Opened Covaxin vial can be stored for 28 days, says Bharat Biotech
-
Results provide evidence for effectiveness: Bharat Biotech on Covaxin study
-
Serum Institute gets nod to export vaccines to COVAX
-
110 countries recognise India's Covishield, Covaxin: Source
-
Developing Covaxin was an enormous challenge: Bharat Biotech
-
Bahrain approves Covaxin for emergency use
-
Covaxin 77.8% per cent effective, says data published in The Lancet
-
Six months after second dose ideal time for booster: Bharat Biotech CMD
-
UK to add India's Covaxin to approved list from Nov 22
-
Bharat Biotech's US partner Ocugen seeks Covaxin approval for kids
-
WHO approves Covaxin, Health Minister hails ICMR, Bharat Biotech scientists
-
Bharat Biotech's Covaxin gets WHO's nod
-
CDSCO approves extension of Covaxin's shelf life to 12 months
-
After Australia, 5 more countries recognise India's Covaxin
-
Covaxin recognized by Australia
-
Post-WHO approval Covaxin, India can supply 5bn dosages to world
-
Let's wait for WHO on Covaxin, SC on plea for re-vaccination by Covishield
-
WHO body seeks more clarification to decide on Covaxin EUL
-
Covaxin gets emergency use approval for kids aged 2-18 years
-
AIPSN expresses concern over WHO not granting EUL for Covaxin
-
Diligently working with WHO to obtain EUL for Covaxin: Bharat Biotech
-
Vaccine must not be entry barrier for nations: Bharat Biotech Co-Founder
-
Covaxin may get WHO approval by month-end, says NITI Aayog
-
Telangana to vaccinate 3 lakh people daily
-
Mandaviya releases 1st commercial batch of Covaxin from Bharat Biotech's new plant
-
Covaxin single-dose to Covid infected equivalent to 2 doses for unaffected: ICMR
-
'Covaxin for children may get DGCI nod before trial period'
